# Bofeng Hu

> Bofeng Hu is a Series C investor at CLSA backing Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [CLSA](https://shizune.co/investors/profile/clsa)
- Total investments: 2
- Last investment: Dec 2022
- Lead investor: 100%
- Last updated: Aug 2026

Bofeng Hu is a Series C investor at CLSA focused on Biotechnology. Mr. Bofeng Hu is the Vice General Manager of Jinshi Investment. He is the Director of CLSA .

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| uBriGene | Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization. | $14.7M | Series C | Dec 23, 2022 |  |
| uBriGene | Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization. | $14.7M | Series C | Dec 23, 2022 |  |

2 of 2 investments shown.

## Co-investors
- [BGI Co-Win](https://shizune.co/investors/profile/bgi-co-win) — VC Fund, 2 deals together
- [FOF Capital](https://shizune.co/investors/profile/fof-capital) — VC Fund, 2 deals together
- [Huagai Capital](https://shizune.co/investors/profile/huagai-capital) — VC Fund, 2 deals together
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 2 deals together
- [Industrial Bank](https://shizune.co/investors/profile/industrial-bank) — VC Fund, 2 deals together
- [Jinshi Investment](https://shizune.co/investors/profile/jinshi-investment) — VC Fund, 2 deals together

## About CLSA

VC Fund · Hong Kong, Hong Kong

CLSA is an investment bank that provides security brokerage and investment banking services.

5 contacts available at CLSA.

| Name | Title | Profile |
| --- | --- | --- |
| Andrew Riddick | Head of Research | https://shizune.co/investors/profile/andrew-riddick |
| Donald Skinner | Executive Chairman, CLSA Capital Partners | https://shizune.co/investors/profile/donald-skinner |
| Gary Coull | Founder | https://shizune.co/investors/profile/gary-coull |
| Jonathan Slone | CEO | https://shizune.co/investors/profile/jonathan-slone |
| Bofeng Hu | Director | https://shizune.co/investors/profile/bofeng-hu-ac6b |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Bofeng Hu invest in?

Bofeng Hu invests primarily in Biotechnology startups, most often at Series C stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Bofeng Hu last invest?

The most recent investment recorded for Bofeng Hu closed in Dec 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co